Bulletin of RSMU

ORIGINAL RESEARCH

The efficacy of CRISPR-Cas9-mediated induction of the CCR5delta32 mutation in the human embryo

Kodyleva TA¹, Kirillova AO¹, Tyschik EA¹, Makarov VV², Khromov AV², Gushchin VA², Abubakirov AN¹, Rebrikov DV^1,3, Sukhikh GT¹

About authors

¹ Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow

² Lomonosov Moscow State University, Moscow, Russia

³ Pirogov Russian National Research Medical University, Moscow, Russia

Correspondence should be addressed: Denis V. Rebrikov
Ostrovityanova 1, Moscow, 117997; moc.liamg@vokirberd

About paper

Received: 2018-09-26 Accepted: 2018-10-09 Published online: 2018-10-17

No data available...

Link to the next paper will be sent to the indicated e-mail's:

ORIGINAL RESEARCH The efficacy of CRISPR-Cas9-mediated induction of the CCR5delta32 mutation in the human embryo

Kodyleva TA, Kirillova AO, Tyschik EA, Makarov VV, Khromov AV, Gushchin VA, Abubakirov AN, Rebrikov DV, Sukhikh GT

Published in "Bulletin of RSMU" 4, 2018

I want to receive a copy of this message

Vancouver style

Kodyleva TA, Kirillova AO, Tyschik EA, Makarov VV, Khromov AV, Gushchin VA, et al. The efficacy of CRISPR-Cas9-mediated induction of the CCR5delta32 mutation in the human embryo. Bulletin of RSMU. 2018; (4): 70–4. DOI: 10.24075/brsmu.2018.052

Harvard style

Kodyleva, T. A., Kirillova, A. O., Tyschik, E. A., Makarov, V. V., Khromov, A. V., Gushchin, V. A., et al. (2018), "The efficacy of CRISPR-Cas9-mediated induction of the CCR5delta32 mutation in the human embryo", Bulletin of RSMU, no. 4, p. 70–74. DOI: 10.24075/brsmu.2018.052

Remember me

Forgot password?

I accept Editorial Policies of the journal

Archive

2018 / 04

ORIGINAL RESEARCH

The efficacy of CRISPR-Cas9-mediated induction of the CCR5delta32 mutation in the human embryo